A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants

Míreanna comhchosúla

• A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
  de réir: Odutola, A, et al.
  Foilsithe / Cruthaithe: (2012)
• Immunogenicity of the Tuberculosis Vaccine MVA85A Is Reduced by Coadministration with EPI Vaccines in a Randomized Controlled Trial in Gambian Infants
  de réir: Ota, M, et al.
  Foilsithe / Cruthaithe: (2011)
• Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
  de réir: Ota, M, et al.
  Foilsithe / Cruthaithe: (2011)
• Differential cytokine levels in adults induced by a Novel candidate TB boost vaccine, MVA85A-according to previous BCG vaccination status
  de réir: Owiafe, P, et al.
  Foilsithe / Cruthaithe: (2012)
• The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
  de réir: Tameris, M, et al.
  Foilsithe / Cruthaithe: (2014)